Liver Transplant research hub

NEurotrophins MImetic compound for modulation of ischemia/reperfusion damage in Liver transplantation with Extended criteria Donors, a phase I/II explorative, open label, controlled, randomized study

This study is looking at a new medicine to protect livers from damage during a transplant operation. It's for people receiving a liver from a donor who might have had less healthy livers. The aim is to see if this medicine helps the new liver work better.